About Dr Chia-chi Liu

Dr Liu’s core research is focused on the study of the redox regulation of the Na+-K+ pump in both animal models and humans. Her innovative research has led to a number of exciting and novel findings, establishing a new direction for the biological effects and the signalling pathways of oxidative stress on the Na+-K+ pump. The intrinsic goal of Dr Liu’s research is to improve the survival and quality of life for patients suffering from cardiovascular disease and cancer.

Dr Liu’s experience and expertise in cell and molecular biology, biotechnology and redox chemistry have enabled her to advance knowledge in the field of the Na+-K+ pump regulation. With this foundation, she uncovers a novel mechanism of sodium pump regulation, with significant clinical implications in both cardiovascular disease and cancer. Her vision of research is to translate the fundamental discoveries from the research findings to establish novel pharmaceutical therapies and treatments for cardiovascular disease; and to design innovative therapeutic proteins for use in cancer treatments.

Dr. Chia-chi Liu is a Research Fellow at the University of Sydney. She majored in Cell and Molecular Biology at Taipei Medical University, Taiwan; obtained her second master degree in Biotechnology at University of New South Wales; and received a PhD in Chemistry and Bio-molecular Science from Macquarie University in 2007. Dr. Liu’s core focus is investigating the relationship between oxidative stress and the sodium pump function. Her research interests include the development of new diagnostic methods for oxidative damage of the pump; the discovery of new drugs for heart disease; and the design of novel therapeutic proteins for cancer treatment. Since 2009, she published more than 20 high impact factor publications with peer-reviewed journals; and has been awarded more than 10 prestigious national project grants. In addition, Dr. Liu has obtained a National Heart Foundation Post-Doctoral Fellowship; and is the inventor for an innovative Australian patent in diagnostic technology.